Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 773

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 7A
Chunk 773
---
,932,033) 
     (2,759,068)

    CASH FLOWS FROM INVESTING ACTIVITIES 

    Purchase of property and equipment 
     (11,111) 
     (15,251)
  
    Net cash used in investing activities 
     (11,111) 
     (15,251)

    CASH FLOWS FROM FINANCING ACTIVITIES 

    Proceeds from sale of common stock and exercise of warrants 
     2,469,150  
     5,332,283 
  
    Proceeds received from line of credit 
     -  
     300,000 
  
    Repayments on line of credit 
     -  
     (1,050,551)
  
    Proceeds received from advances, related party 
     -  
     1,295,010 
  
    Repayments on advances, related party 
     -  
     (1,095,000)
  
    Repayments on notes payable 
     (410,676) 
     (185,692)
  
    Proceeds received from convertible notes payable 
     -  
     1,455,000 
  
    Net cash provided by financing activities 
     2,058,474  
     6,051,050 

    NET CHANGE IN CASH AND CASH EQUIVALENTS 
     (884,670) 
     3,276,731 
  
    CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 
     3,280,075  
     3,344 
  
    CASH AND CASH EQUIVALENTS AT END OF PERIOD 
    $2,395,405  
    $3,280,075 

    SUPPLEMENTAL INFORMATION: 

    Interest paid 
    $15,600  
    $36,226 
  
    Income taxes paid 
    $-  
    $- 

    NON-CASH INVESTING AND FINANCING ACTIVITIES: 

    Initial recognition of right-of-use asset and lease liability 
    $325,491  
    $- 
  
    Cancellation of Class A common stock 
    $-  
    $42 
  
    Non-cash application of invoices to STLogics loan 
    $-  
    $200